GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
7.55
+0.04 (0.53%)
At close: Oct 24, 2024, 4:00 PM
7.50
-0.05 (-0.66%)
After-hours: Oct 24, 2024, 4:00 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $392.81 million as of October 24, 2024. Its market cap has decreased by -11.17% in one year.
Market Cap
392.81M
Enterprise Value
187.01M
1-Year Change
-11.17%
Ranking
Category
Stock Price
$7.55
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $392.81M, a decrease of -51.40%. That is a compound annual growth rate of -19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 390.70M | 29.50% |
| Dec 29, 2023 | 301.70M | -40.33% |
| Dec 30, 2022 | 505.60M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 449.98M |
| National Research | 446.15M |
| GRAIL | 443.07M |
| Zevra Therapeutics | 438.83M |
| COMPASS Pathways | 435.63M |
| C4 Therapeutics | 430.59M |
| Theravance Biopharma | 430.51M |
| 4D Molecular Therapeutics | 429.27M |